Overview
- Description
Pharmaceutical company focused on the small molecule drug NTP42 for the treatment of pulmonary arterial hypertension (PAH).
- Website
- Country
- Ireland
- Sector
- Health Biotechnology
Engage with ATXA Therapeutics Ltd*
*By clicking here you will be leaving the official EIC website and you will be directed to the Dealroom.co domain, an official EISMEA contractor for the EIC investor matchmaking platform.
